JPMorgan Chase & Co (JPM)

Toronto, Ontario and New York, New York--(Newsfile Corp. - January 30, 2025) - QuantGate Systems Inc. (OTCQB: QGSI) (the "QuantGate"...

Wall Street is heading into 2025 with strong results and high hopes for the year ahead. A recent report from Morningstar DBRS Inc. highlights how major banks performed well in the last quarter of 2024, signaling a bright future for investment banking.

Jennifer Piepszak, Chief Operating Officer of JPMorgan Chase & Co., will present at the BofA Financial Services Conference at the 1 Hotel in Miami Beach, Florida on Tuesday, February 11, 2025 at 1:00 p.m. (Eastern).

Jeremy Barnum, Chief Financial Officer of JPMorgan Chase & Co., will present at the UBS Financial Services Forum at the Ritz Carlton Hotel in Key Biscayne, Florida on Tuesday, February 11, 2025 at 9:40 a.m. (Eastern).

JPMorgan Chase & Co. (NYSEJPM) (“JPMorganChase” or the “Firm”) has made an announcement concerning its preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.

Red Badger, a leader in digital transformation for some of the world’s most prominent brands and financial institutions, is proud to announce the launch of its dedicated Public Sector practice. This new initiative will bring the company’s deep digital expertise, innovative methods, and progressive technologies to the public sector, helping organisations tackle complex challenges with cutting-edge, highly effective digital solutions.

In the current market environment, “Real-World Assets” (RWA, real-world assets) are rapidly rising.As Trump is confirmed to be the next president of the United States, he has begun to advocate and attach importance to crypto assets. Traditional financial giants such as Citigroup, BlackRock, Fidelity and JP Morgan Chase have also stepped in.RWA narratives have seen the second-largest growth so far this year, up 117%, behind only Meme, according to Dune Analytics. RWA has not only become one of the important narratives of the bull market, but has also become a bridge linking the crypto market with mainstream finance, introducing traditional funds into the crypto market. RWA has many different types of tokenization (both tangible and intangible assets) such as commercial real estate, bonds, cars, and almost any asset that stores value can be tokenized.

Mahendravarman Sampathu, product owner and site reliability engineer at JP Morgan Chase, has been appointed judge for the Global Recognition Awards. Renowned for his expertise in technological innovation and operational excellence, he brings extensive experience in cost optimization and strategic system development.

PHOENIX, Ariz., Jan. 16, 2025 (SEND2PRESS NEWSWIRE) -- Twenty-two entrepreneurs graduated from the Impact AZ 2025 Supplier Diversity Accelerator on Tuesday, January 14, during a ceremony held at the Arizona Public Service (APS) Headquarters in Phoenix, the Black Chamber of Arizona announced today. - News from Black Chamber of Arizona, issued by Send2Press Newswire

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Focusing on Neuroscience, Oncology, and Ophthalmology Pipelines

JPMorgan Chase & Co. (NYSEJPM) (“JPMorganChase” or the “Firm”) has declared dividends on the outstanding shares of the Firm’s Series DD, EE, GG, JJ, KK, LL, MM and NN preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.

In December, JPMorgan Chase & Co. disclosed its 5.3% stake in Brera Holdings (NASDAQBREA) via an SEC 6K filing, highlighting Chase’s aggregate ownership of 351,400 Class B Ordinary Shares of Brera. “The disclosure showcases JPMorgan Chase’s role as a major institutional investor, reinforcing its influence in shaping the governance and strategic decisions of Brera Holdings. This stake may reflect JPMorgan’s belief in the long-term potential of Brera’s innovative multi-club sports ownership model and its global expansion strategy,” reads a recent article. The piece also highlights Brera’s recent investment in Juve Stabia, an Italian Serie B soccer club, which aligns with the company’s multi-club ownership strategy. “Brera’s dynamic approach reflects its aspirations to be a transformative player in sports ownership, with an innovative model focused on multi-club football ownership, global branding strategies, community initiatives and community-driven social and cultural projects.”

JPMorgan Chase & Co. has released its fourth-quarter and full-year 2024 financial results. Results can be found at the Firm’s Investor Relations website at jpmorganchase.com/ir/quarterly-earnings.

Atlanta, Georgia--(Newsfile Corp. - January 14, 2025) - Ammunition, an Atlanta-based full-funnel advertising agency, has appointed Kate Grafton as Vice...

JPMorgan Chase today announced new responsibilities for several senior executives as it continues to build on its leadership positions across global financial services.

As 2025 kicks off, several companies are standing out as stocks to watch, driven by groundbreaking technologies, strategic market positioning, and strong growth potential. From cutting-edge oncology treatments to defense technology innovations and wellness solutions, these companies are making waves across various sectors. Here's a closer look at stocks like Phio Pharmaceuticals (NASDAQPHIO), LightPath Technologies NASDAQ: LPTHNASDAQLPTH)(NASDAQ: KAVLNASDAQKAVL, and more, making headlines and capturing investor attention.

The Company will present at the Annual J.P. Morgan Healthcare Conference, providing business updates on its sarcoma franchise and other...

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage company developing antiviral drugs designed to resist viral escape, announced it will present at the Biotech Showcase 2025 on Jan. 14 in San Francisco. Anil R. Diwan, PhD, the company’s president and executive chairman, will provide updates on NanoViricides’ pipeline, including NV-387, a Phase II-ready drug with potential applications against a wide range of viral infections such as influenza, RSV, MPox, smallpox, and COVID-19. NV-387 is engineered to target host-side features essential for viral infections, offering potential advantages over current treatments. The company will also showcase its platform for oral delivery of non-oral drugs, which could meet significant market demand. The market potential for NV-387’s indications exceeds $10 billion. Biotech Showcase runs parallel to the JP Morgan Life Sciences Conference, offering a key networking venue for therapeutic development executives and investors.

Salt Lake City, Utah--(Newsfile Corp. - January 9, 2025) - BioUtah, the trade association,...

JPMorganChase, Axios, and the U.S. Conference of Mayors today announced the launch of Zoom In, a partnership designed to share and scale insights on driving local economic growth and prosperity in communities across the country. The partnership will feature how local elected officials, community and business leaders, and policy experts are working together to set and drive an agenda that moves their communities forward, from housing and inflation to health care and the impact of new innovations on the workforce.

SINGAPORE - Media OutReach Newswire - 9 January 2025 - SUNRATE, the global payment and treasury management platform, kickstarts the new year by introducing...

There is a renewed sense of optimism among small and midsize business leaders as they consider their business and economic prospects for the year ahead, according to JPMorganChase’s 2025 Business Leaders Outlook survey released today. Compared to a year ago, confidence in the national economy has jumped 12 percentage points to 55% among small business owners, and more than doubled from 31% to 65% among midsize business leaders. This upbeat attitude extends to their own companies, with three-quarters of respondents expressing a positive outlook for the next 12 months.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ATLANTA, GA - January 6, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that David Dodd, Chief Executive Officer, will review 2024 progress in a presentation at the Biotech Showcase coinciding with the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, January 13-16, 2025.